Peter Langhorne1, Martin J O'Donnell2, Siu Lim Chin3, Hongye Zhang4, Denis Xavier5, Alvaro Avezum6, Nandini Mathur5, Melanie Turner7, Mary Joan MacLeod7, Patricio Lopez-Jaramillo8, Albertino Damasceno9, Graeme J Hankey10, Antonio L Dans11, Ahmed Elsayed12, Charles Mondo13, Mohammad Wasay14, Anna Czlonkowska15, Christian Weimar16, Afzal Hussein Yusufali17, Fawaz Al Hussain18, Liu Lisheng19, Hans-Christoph Diener16, Danuta Ryglewicz15, Nana Pogosova20, Romana Iqbal14, Rafael Diaz21, Khalid Yusoff22, Aytekin Oguz23, Xingyu Wang4, Ernesto Penaherrera24, Fernando Lanas25, Okechukwu S Ogah26, Adesola Ogunniyi27, Helle K Iversen28, German Malaga29, Zvonko Rumboldt30, Daliwonga Magazi31, Yongchai Nilanont32, Annika Rosengren33, Shahram Oveisgharan34, Salim Yusuf3. 1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: peter.langhorne@glasgow.ac.uk. 2. Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada; Health Research Board Clinical Research Facility, Department of Medicine, NUI Galway, Galway, Ireland. 3. Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. 4. Beijing Hypertension League Institute, Beijing, China. 5. St John's Medical College and Research Institute, Bangalore, India. 6. Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil. 7. Division of Applied Medicine, University of Aberdeen, Aberdeen, UK. 8. Instituto de Investigaciones FOSCAL, Escuela de Medicina, Universidad de Santander, Bucaramanga, Colombia. 9. Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique. 10. Medical School, The University of Western Australia, Perth, WA, Australia. 11. College of Medicine, University of Philippines, Manila, Philippines. 12. Alzaeim Alazhari University, Khartoum North, Sudan. 13. Uganda Heart Institute, Mulago Hospital, Kampala, Uganda. 14. Department of Medicine, Aga Khan University, Karachi, Pakistan. 15. Institute of Psychiatry and Neurology, Warsaw, Poland. 16. Department of Neurology, University Hospital, Essen, Germany. 17. Dubai Health Authority, Dubai Medical College, Dubai, United Arab Emirates. 18. King Saud University, Riyadh, Saudi Arabia. 19. National Center of Cardiovascular Disease, Beijing, China. 20. National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, Moscow, Russia. 21. Estudios Clinicos Latinoamerica, Rosario, Argentina. 22. UCSI University, Cheras, Kuala Lumpur, Malaysia. 23. Istanbul Medeniyet Üniversitesi, Istanbul, Turkey. 24. Department of Cardiology, Hospital Luis Vernaza, Guayaquil, Ecuador. 25. Faculty of Medicine, Universidad de La Frontera, Temuco, Chile. 26. Division of Cardiovascular Medicine, University College Hospital, Ibadan, Nigeria. 27. Department of Medicine, University College Hospital, Ibadan, Nigeria. 28. Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 29. Universidad Peruana Cayetano Heredia, Lima, Peru. 30. University of Split, Split, Croatia. 31. University of Limpopo, Pretoria, South Africa. 32. Neurology Division, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. 33. Sahlgrenska Academy and University Hospital, University of Gothenburg, Gothenburg, Sweden. 34. Rush Alzheimer Disease Research Center in Chicago, Chicago, IL, USA.
Abstract
BACKGROUND: Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels. METHODS: We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month. FINDINGS: We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14-1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12-1·72) irrespective of other patient and service characteristics. INTERPRETATION: Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes. FUNDING: Chest, Heart and Stroke Scotland.
BACKGROUND:Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels. METHODS: We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 strokepatients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month. FINDINGS: We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14-1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12-1·72) irrespective of other patient and service characteristics. INTERPRETATION: Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes. FUNDING: Chest, Heart and Stroke Scotland.
Authors: Amir Abdallah; Jonathan L Chang; Cumara B O'Carroll; Samson Okello; Sam Olum; Moses Acan; Abdirahim Abdi Aden; Felicia C Chow; Mark J Siedner Journal: Stroke Date: 2018-12 Impact factor: 7.914
Authors: Rasha Khatib; Yurany A Arevalo; Mark A Berendsen; Shyam Prabhakaran; Mark D Huffman Journal: Neuroepidemiology Date: 2018-07-19 Impact factor: 3.282
Authors: Mina A Jacob; Merel S Ekker; Youssra Allach; Mengfei Cai; Karoliina Aarnio; Antonio Arauz; Marcel Arnold; Hee-Joon Bae; Lucrecia Bandeo; Miguel A Barboza; Manuel Bolognese; Pablo Bonardo; Raf Brouns; Batnairamdal Chuluun; Enkhzaya Chuluunbatar; Charlotte Cordonnier; Byambasuren Dagvajantsan; Stephanie Debette; Adi Don; Chris Enzinger; Esme Ekizoglu; Simon Fandler-Höfler; Franz Fazekas; Annette Fromm; Thomas Gattringer; Thiago F Hora; Christina Jern; Katarina Jood; Young Seo Kim; Steven Kittner; Timothy Kleinig; Catharina J M Klijn; Janika Kõrv; Vinod Kumar; Keon-Joo Lee; Tsong-Hai Lee; Noortje A M Maaijwee; Nicolas Martinez-Majander; João P Marto; Man M Mehndiratta; Victoria Mifsud; Vinícius Montanaro; Gisele Pacio; Vinod B Patel; Matthew C Phillips; Bartlomiej Piechowski-Jozwiak; Aleksandra Pikula; Jose Ruiz-Sandoval; Bettina von Sarnowski; Richard H Swartz; Kay-Sin Tan; David Tanne; Turgut Tatlisumak; Vincent Thijs; Miguel Viana-Baptista; Riina Vibo; Teddy Y Wu; Nilüfer Yesilot; Ulrike Waje-Andreassen; Alessandro Pezzini; Jukka Putaala; Anil M Tuladhar; Frank-Erik de Leeuw Journal: Neurology Date: 2021-12-14 Impact factor: 9.910
Authors: Morgan L Prust; Amir Mbonde; Clio Rubinos; Gentle S Shrestha; Morenikeji Komolafe; Deanna Saylor; Halinder S Mangat Journal: Neurocrit Care Date: 2022-07-16 Impact factor: 3.532
Authors: Aaron Berkowitz; Nirali Vora; Morgan L Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S Shrestha Journal: Stroke Date: 2022-01-20 Impact factor: 7.914
Authors: Rasha Khatib; Assef M Jawaadah; Umaieyh Khammash; Ahmed Babiker; Mark D Huffman; Shyam Prabhakaran Journal: J Am Heart Assoc Date: 2018-11-20 Impact factor: 5.501
Authors: Paula Muñoz Venturelli; Jason P Appleton; Craig S Anderson; Philip M Bath Journal: Curr Neurol Neurosci Rep Date: 2018-09-18 Impact factor: 5.081